Intravenous Hydrocortisone versus Intravenous Dexamethasone in Children Hospitalized with Acute Severe Asthma aged 2 to 14 years
Phase 3
- Conditions
- Health Condition 1: J455- Severe persistent asthma
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children diagnosed with acute severe asthma consistent with severity as per Global Initiative for Asthma Guidelines and Pediatric Asthma Severity Score
Exclusion Criteria
I. Patients with cardiovascular, neurological, psychiatric, neoplastic, or renal disease.
II. Patients with respiratory conditions like pneumonia, pneumothorax, or
pneumomediastinum will be excluded.
III. Those children whose parents refused to give consent to participate in the study.
IV. Children who have received any systemic steroid preparations in the last 15 days before
hospital arrival.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method